Board Recertification Intensive Studies: Chronic Obstructive Pulmonary Disease: New Approaches to an Old Problem

Description

New treatments for chronic obstructive pulmonary disease (COPD)—including monotherapy and combination agents approved by the U.S. Food and Drug Administration—raise questions for pharmacists about when and where to put these therapies to most effective use. In this interactive session, experts will use real-world cases to share practical approaches on how to assess patients with COPD. With a comparison of old versus new therapies, you will leave with the practical skills needed to manage patients in both inpatient and outpatient settings.

Select Intensive Studies for Recertification 2018 when you register for APhA2018  to purchase the intensive studies exam for BPS recertification credit. Cost: $50.00

Pharmacist Learning Objectives

At the completion of this application-based activity, participants will be able to: 

  1. Interpret data from clinical trials of newly approved therapeutic approaches for chronic obstructive pulmonary disease (COPD).
  2. Describe recommendations in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for the Diagnosis, Management, and Prevention of COPD.
  3. Discuss the pros and cons of new and old approaches to managing COPD.
  4. Recommend appropriate therapy for COPD in patients across inpatient and outpatient settings.
 
 
 
Speakers:
Dennis
Dennis Williams, PHARMD, FAPHA
Pharmacist
University of North Carolina At Chapel Hill Eshelman School of Pharmacy
 
Lori
Lori Wilken,
University of Illinois
 
Learning Level: Level 2
Track: Clinical Patient Care and Services, Board Recertification
Session Time Slot(s): 
Date: 
Sunday, March 18
Time: 
3:30 PM - 5:30 PM
Room: 
Music City Center - Room 103C
ACPE Pharmacist: 0202-0000-18-011-L04-P
CEUs Pharmacist: 0.2
Activity Type:
Application-based